BASF's $12.3 billion acquisition move collapsed
Original headlineBASF'nin 12,3 milyar dolarlık satın alma hamlesi çöktü
Not investment advice. Muhabbit scores how much a story may matter, not which way to trade.
BASF has ended talks to acquire Evonik after its roughly $12.3 billion takeover proposal was rejected, withdrawing an offer of €24 per share. Evonik shares fell sharply following the collapse of the deal. The move would have been one of the German chemical giant’s largest acquisitions, consolidating two major players in specialty chemicals. Investors will now watch whether BASF pursues alternative targets or returns capital, and whether Evonik faces pressure to deliver standalone value or attract other suitors.
Muhabbit's AI wrote this summary in its own words from Dünya's report and translated it from Turkish. It can get details wrong, so check the source.
Named in this story
Evonik, BASF